Rheumatologists and dermatologists highlight Saphnelo, Sotyktu, and litifilimab as leading candidates to address unmet needs in CLE patients, particularly those with systemic involvementEXTON, PA, ...

Additional testing in the evaluation of lupus patients with NPSLE includes ... should be obtained to determine the subtle but common lesions of Libman–Sacks endocarditis. [91] However, there ...

Background: Several studies have demonstrated an increased risk of periodontitis (PD) among patients diagnosed with systemic lupus erythematosus (SLE). However, the underlying common mechanism between ...

Oral options are emerging, but few match the broad therapeutic impact seen with HTD1801. In addition to its impact on glucose control, the drug’s influence on hepatic markers and lipid profiles ...

Background: Systemic lupus erythematosus (SLE) is a persistent autoimmune disorder ... Since abnormal fibroblast proliferation is a key factor in the pathogenesis of SLE skin lesions, and apoptosis ...

Mononeuritis multiplex affects 1%–9% of people with systemic lupus erythematosus and requires urgent interspecialty ... She was discharged home with prescriptions for oral prednisone 5 mg/d for 7 days ...